Author + information
- Şahin Şenay1,
- Ahmet Ümit Güllü1,
- Muharrem Koçyiğit2,
- Aleks Değirmencioğlu3,
- Leyla Kılıç4,
- Hasan Karabulut1 and
- Cem Alhan1
We report a case series of robotic mitral valve replacement in patients with severe rheumatic mitral disease.
From March 2010 to May 2013, a total of 61 patients underwent robotic cardiac procedures. Robotic procedures were performed using the da Vinci Si surgical systems (Intuitive Surgical, Inc, Sunnyvale, CA). Seventeen of the patients (27.9%) underwent robotic mitral valve replacement. Rheumatic disease was the underlying pathology in all patients. Mean follow up period was 17±11 months.
Mean age and Euroscore (%) of the patients were 50.2±11 and 4.2±4. Seven patients (41.1%) had additional cardiac procedure. No operative and hospital mortality was observed. Mean cross clamp time and cardiopulmonary bypass time were 118±35 and 182±55 minutes, mean drainage was 440±352 ml, mean intubation time was 9.8±7.2 hours, the rate of patients extubated within ≤6 hours was 94.1 %, mean intensive care unit stay time was 31±14 hours. Fifteen of the patients (88.2%) were discharged from the intensive care unit within the postoperative first 24 hours. During the intensive care unit stay one patient (5.8%) needed inotropic support. There was one early reoperation for bleeding (5.8%). There was one (5.8%) intensive care unit readmission and one (%5.8) hospital readmission observed. During the late follow up there was no mortality and no need for reoperation or reintervention.
Robotic mitral valve replacement for severe rheumatic mitral disease is technically feasible. Early results are encouraging. Patient selection criteria for robotic mitral valve surgery may be expanded to include valve replacements.